Pacira BioSciences Announces CFO Departure, New CFO & Directors
Ticker: PCRX · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 8-K |
| Filed Date | Jan 21, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, board-change, cfo
Related Tickers: PCRX
TL;DR
Pacira BioSciences CFO out, new CFO in, two new directors elected. #leadershipchange
AI Summary
Pacira BioSciences, Inc. announced on January 16, 2025, the departure of its Chief Financial Officer, Hubert "Hub" Davis. The company also announced the appointment of John "Jack" W. Gallagher as the new Chief Financial Officer, effective January 16, 2025. Additionally, the company reported that its Board of Directors elected two new directors, Dr. David J. Enders and Ms. Susan L. Miller, effective January 16, 2025.
Why It Matters
Changes in key executive and board positions can signal shifts in company strategy or financial oversight, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and financial management.
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- Hubert "Hub" Davis (person) — Departing Chief Financial Officer
- John "Jack" W. Gallagher (person) — Appointed Chief Financial Officer
- Dr. David J. Enders (person) — Elected Director
- Ms. Susan L. Miller (person) — Elected Director
- January 16, 2025 (date) — Effective date of changes
FAQ
Who has been appointed as the new Chief Financial Officer of Pacira BioSciences, Inc.?
John "Jack" W. Gallagher has been appointed as the new Chief Financial Officer, effective January 16, 2025.
Who is departing as the Chief Financial Officer of Pacira BioSciences, Inc.?
Hubert "Hub" Davis is departing as the Chief Financial Officer.
When were the changes in executive and board positions effective?
The changes were effective January 16, 2025.
How many new directors were elected to the Board of Directors?
Two new directors, Dr. David J. Enders and Ms. Susan L. Miller, were elected.
What is the exact date of the report for these events?
The date of the report is January 21, 2025, with the earliest event reported on January 16, 2025.
Filing Stats: 1,040 words · 4 min read · ~3 pages · Grade level 12 · Accepted 2025-01-21 08:05:03
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share PCRX Nasdaq Global Select Mar
Filing Documents
- pcrx-20250116.htm (8-K) — 34KB
- ex101-ar2014inducementplan.htm (EX-10.1) — 91KB
- ex102-ar2014inducementplan.htm (EX-10.2) — 26KB
- ex103-ar2014inducementplan.htm (EX-10.3) — 37KB
- pcrx-newccopressreleasejan.htm (EX-99.1) — 30KB
- paciralogo2025a.jpg (GRAPHIC) — 80KB
- 0001396814-25-000017.txt ( ) — 494KB
- pcrx-20250116.xsd (EX-101.SCH) — 2KB
- pcrx-20250116_lab.xml (EX-101.LAB) — 22KB
- pcrx-20250116_pre.xml (EX-101.PRE) — 13KB
- pcrx-20250116_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On January 21, 2025, the Company issued a press release announcing the leadership changes. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01 and Exhibit 99.1 furnished hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 10.1 Amended and Restated 2014 Inducement Plan . 10.2 Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2014 Inducement Plan . 10.3 Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Inducement Plan . 99.1 P ress Release dated January 21, 2025 . 104 Cover Page Interactive Data File (Formatted as Inline XBRL) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PACIRA BIOSCIENCES, INC. (REGISTRANT) Dated: January 21, 2025 By: /s/ KRISTEN WILLIAMS Kristen Williams Chief Administrative Officer and Secretary